14-10-2026 17:37 via drugs.com

EASD: Petrelintide Achieves Weight Loss for Adults With Obesity

WEDNESDAY, Oct. 14, 2026-- The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity, according to a study published online Sept. 29 in The Lancet Diabetes & Endocrinology to coincide with the annual...
Read more »

Pharmaceutical news



Prepregnancy HPV Vaccination Linked to Lower Risk for Adverse Pregnancy Outcomes
Surrogates Less Likely to Recommend Life-Sustaining Treatment for Patients With Dementia
AHA: Increased Potassium Intake With DASH Diet Does Not Lead to Hyperkalemia
AAO: Raytracing-Guided LASIK Enhancement Improves Visual Function After Cataract Surgery
Active Acupressure Offers Clinical Benefits for Rosacea
EASD: Daily Orforglipron Pill Shows Comparable Cardiovascular Safety to Insulin Glargine
Herpes ‘Remedies’ Sold On Amazon And Walmart Pose Public Health Risk, FDA Warns
Dementia Expected To Double Worldwide By 2050
Could PMOS/PCOS Affect Memory And Increase Dementia Risk?
Exercise Can Help Women In Menopause Feel Better
Horseback Riding Eases Hyperactivity In Kids With Autism, Study Says
Cardiac Rehab Struggling To Keep Up With Heart Disease Worldwide
Guideline Developed for Treatment of Menopausal Vasomotor Symptoms
AAP Updates Recommendations on Management of UTI in Children Younger Than 5
Desktop versie